Historical salary details - Mr. Stuart A. Arbuckle, Executive Vice President and Chief Operating Officer, Vertex Pharmaceuticals, Inc.
Mr. Stuart A. Arbuckle has been the Executive Vice President and Chief Operating Officer of Vertex Pharmaceuticals, Inc. since 12 Feb 2012. View his historical salary.
Mr. Stuart A. Arbuckle
Executive Vice President and Chief Operating Officer
-
Gross Remuneration
-
Current Company
Vertex Pharmaceuticals, Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Operating Officer | - | - |
| 2024 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Operating Officer | - | - |
| 2023 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Operating Officer | 9.0 M | -40.0 % |
| 2022 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Operating Officer | 15.0 M | 92.0 % |
| 2021 | Vertex Pharmaceuticals, Inc. | - | 7.8 M | 7.2 % |
| 2021 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Operating Officer | 7.8 M | 7.2 % |
| 2020 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | 7.3 M | 6.2 % |
| 2020 | Vertex Pharmaceuticals, Inc. | - | 7.3 M | 6.2 % |
| 2020 | Vertex Pharmaceuticals, Inc. | - | 7.3 M | 6.2 % |
| 2019 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | 6.9 M | 28.3 % |
| 2019 | Vertex Pharmaceuticals, Inc. | - | 6.9 M | 28.3 % |
| 2019 | Vertex Pharmaceuticals, Inc. | - | 6.9 M | 28.3 % |
| 2018 | Vertex Pharmaceuticals, Inc. | - | 5.3 M | - |
| 2018 | Vertex Pharmaceuticals, Inc. | - | 5.3 M | - |
| 2018 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | 5.3 M | - |
| 2017 | Vertex Pharmaceuticals, Inc. | - | 4.4 M | -20.9 % |
| 2017 | Vertex Pharmaceuticals, Inc. | - | 4.4 M | -20.9 % |
| 2017 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | - | - |
| 2016 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | 5.6 M | -37.0 % |
| 2016 | Vertex Pharmaceuticals, Inc. | - | 5.6 M | -37.0 % |
| 2015 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | 8.8 M | -41.9 % |
| 2015 | Vertex Pharmaceuticals, Inc. | - | 8.8 M | -41.9 % |
| 2014 | Vertex Pharmaceuticals, Inc. | - | 15.2 M | 215.4 % |
| 2014 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | 15.2 M | 215.4 % |
| 2014 | Vertex Pharmaceuticals, Inc. | - | 15.2 M | 215.4 % |
| 2013 | Vertex Pharmaceuticals, Inc. | - | 4.8 M | 0.2 % |
| 2013 | Vertex Pharmaceuticals, Inc. | - | 4.8 M | 0.2 % |
| 2013 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | 4.8 M | 0.2 % |
| 2012 | Vertex Pharmaceuticals, Inc. | - | 4.8 M | - |
| 2012 | Vertex Pharmaceuticals, Inc. | - | 4.8 M | - |
| 2012 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Commercial Officer | 4.8 M | - |